Target intelligence / Profile preview

NSA2 pseudogene 6 (NSA2P6)

Target
NSA2P6
Molecular classification
Other (Pseudogene)
01

Overview

**NSA2 pseudogene 6 (NSA2P6)** is a predicted pseudogene related to the functional NSA2 gene, which encodes a nucleolar protein involved in ribosome biogenesis and cell proliferation[1]. Pseudogenes like NSA2P6 are DNA sequences that resemble protein-coding genes but contain defects (such as frameshifts and stop codons) that prevent them from producing functional proteins[5][6][7]. While some pseudogenes participate in regulatory RNA mechanisms affecting their parent genes, there is no evidence that NSA2P6 has a functional role, is a therapeutic target, or is associated with any diseases or drugs. The existence and naming of "NSA2 pseudogene 6" indicate a non-functional, likely unstudied element of the genome, not a receptor, enzyme, or traditional molecular target.\n\n**Context and Explanation:**\n- **NSA2** is a protein-coding gene with clear biological functions in ribosome biogenesis and cell proliferation, and has several pseudogenes[1]. \n- **Pseudogenes** are generally considered nonfunctional genomic sequences, though some (not all) can act as regulatory RNAs or microRNA decoys under certain conditions[3][4].\n- No sources list “NSA2 pseudogene 6 (NSA2P6)” as a therapeutic or drug-targetable molecule, receptor, enzyme, transporter, or biomarker[1][2][3][4][5][6][7].\n- There is no evidence for interacting drugs or mechanisms of action related to this pseudogene.\n\n**Errors/Concerns:**\n- **is_incorrect = true**: “NSA2 pseudogene 6” is not a valid therapeutic target or receptor, nor does it refer to a functional or druggable protein, so it does not match the definition of a target molecule or receptor[5][6][7]. \n- Entries for drugs, biomarkers, safety, and detailed functions are left null due to the absence of evidence for NSA2P6 beyond its classification as a pseudogene.

02

Biological functions

Other (No known biological function; pseudogenes can sometimes regulate parent gene expression via RNA mechanisms, but no evidence for NSA2P6 specifically[3][4][5][6][7])
03

Disease associations

Other (No disease association known for this specific pseudogene; generally, pseudogenes can sometimes be biomarkers or implicated in disease, but no evidence for NSA2P6[3][4][2])

Beyond the preview

Go deeper on NSA2 pseudogene 6 (NSA2P6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NSA2 pseudogene 6 (NSA2P6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call